Drugs / C13 N15 Valine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02305056 | Sep 2014 → Jan 2018 | glioma | University Hospital, Grenoble | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C13 N15 Valine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02305056 ↗ |